Related Experiment Videos
Infarct size--can it be measured or modified in humans?
Abstract:
Despite more than 15 years of intensive experimental and clinical research in the general area of limiting infarct size, no treatment has been shown to be so efficacious and relatively free of side effects that its routine use can be recommended. In addition, there is no ideal means of measuring infarct size as yet. However, considerable progress has been made in understanding mechanisms responsible for irreversible cellular injury and in identifying factors and anatomic alterations responsible for or contributing to the development of transmural (Q wave) and non-transmural (non-Q wave) myocardial infarcts. Interventions are available that are capable of causing rapid coronary thrombolysis, and techniques are becoming available tht have increasing power to size myocardial infarcts and estimate both segmental and ventricular function. Experimental studies have also suggested a potential benefit from a combination of reperfusion therapy with selected pharmacologic intervention in reducing infarct size and preserving ventricular function. It seems likely that this general area will remain an intensive area of clinical research in the immediate future.
Insights
Despite extensive research, no single treatment effectively limits infarct size without side effects. New methods improve infarct measurement and understanding of cardiac injury mechanisms.
Area of Science:
- Cardiology
- Cardiovascular Research
Background:
- Over 15 years of research has focused on limiting infarct size.
- No treatment is currently recommended for routine use due to efficacy and side effect concerns.
- Ideal methods for measuring infarct size are still lacking.
Purpose of the Study:
- To review progress in understanding myocardial infarct mechanisms.
- To highlight advancements in infarct size measurement and therapeutic interventions.
- To discuss the potential of combined reperfusion and pharmacologic therapies.
Main Methods:
- Review of experimental and clinical research on infarct size limitation.
- Analysis of mechanisms of cellular injury in myocardial infarction.
- Evaluation of current and emerging techniques for infarct sizing and functional assessment.
Main Results:
- Significant progress in understanding irreversible cellular injury and factors contributing to infarct development.
- Availability of rapid coronary thrombolysis interventions.
- Development of advanced techniques for infarct sizing and ventricular function estimation.
Conclusions:
- Despite challenges, understanding of myocardial infarction mechanisms has advanced.
- Emerging therapies, including combined reperfusion and pharmacologic interventions, show promise.
- Limiting infarct size and preserving ventricular function remain critical areas for future clinical research.